For 10-15, refer to the problem below. (3 pts. each) A non-compensatory model must be done to select the best vaccine av

[answerhappygod]

For 10 15 Refer To The Problem Below 3 Pts Each A Non Compensatory Model Must Be Done To Select The Best Vaccine Av 1 (105 KiB) Viewed 15 times

For 10 15 Refer To The Problem Below 3 Pts Each A Non Compensatory Model Must Be Done To Select The Best Vaccine Av 2 (25.27 KiB) Viewed 15 times

For 10-15, refer to the problem below. (3 pts. each) A non-compensatory model must be done to select the best vaccine available today to fight the COVID-19 and to control its spread. Supposed that the government of the Philippines will be completely replaced with more competent governance, and you will sit for the position of Department of Health, conduct the analysis and recommend the best vaccine. So far, here are the data outsourced from different credible sites: Attributes Pfizer P2,379 Moderna P3,904 AstraZeneca P610 Sinovac P3,629.50 Novavax P366 ≥ 18 years Cost Authorized Groups Efficacy (at full > 16 years old ≥ 18 years old ≥ 18 years old 18-59 years old old 94% 95% 62% 78% 89.7% dose) Storage Requirement -70°C -20°C 7°C 7°C -7°C Shelf-life after 5 days 30 days 180 days 180 days 180 days Thawed Impact to Fair Fair N/A N/A Good COVID-variant FDA-Emergency Granted Granted Granted N/A N/A Use Authorization Protein Delivery Method mRNA mRNA Viral Vector Viral Vector Subunit You are only willing to pay at most P3,000 for the vaccination and having taken courses under epidemiology, here are some points that you have set: 1. Under the delivery method: mRNA > Protein Subunit > Viral Vector. 2. A longer shelf-life is better for efficient containment. 3. In terms of significance: Efficacy > FDA-EUA > Impact to Covid Variant > Shelf-life > Cost > Storage Requirement > Authorized Groups > Delivery Method. Some of the important factors are: a. The age limit of the population is 100 years old. It is in ratio scale. b. If data is not available, it is considered poor or 1 (in ordinal to ratio scale). Percentages can be directly converted as ratings. c. 10. Under dominance check, which vaccine will be selected among the alternative? (3 pts.) 11. Considering your preference for delivery method as either Protein Subunit or mRNA, and the vaccine being FDA-EU Authorized, which shall be selected among the alternatives by satisficing? Take note that for the other attributes, the values under each attribute are within your set range. (3 pts.) 12. Using disjunctive resolution, how many vaccines shall be eliminated? 13. If lexicography is applied considering the given significance, which vaccine will be selected?
14. If lexicography is applied considering FDA-EUA > Impact to Covid Variant > Cost > Efficacy > Shelf-life > Storage Requirement > Authorized Groups > Delivery Method, which vaccine will be selected? 15. Is it possible to select the best vaccine if dominance check is used, followed by satisficing in number 11? A. Yes. B. No. C. Maybe. D. Insufficient data.